
BrightSpring Health (BTSG) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
2.9B
Gross Profit
338.4M
11.76%
Operating Income
50.7M
1.76%
Net Income
29.0M
1.01%
EPS (Diluted)
$0.14
Balance Sheet Metrics
Total Assets
5.8B
Total Liabilities
4.2B
Shareholders Equity
1.7B
Debt to Equity
2.46
Cash Flow Metrics
Operating Cash Flow
57.8M
Free Cash Flow
84.0M
Revenue & Profitability Trend
BrightSpring Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 11.3B | 8.8B | 7.7B | 6.7B | 5.6B |
Cost of Goods Sold | 9.7B | 7.4B | 6.4B | 5.4B | 4.5B |
Gross Profit | 1.6B | 1.4B | 1.4B | 1.2B | 1.0B |
Gross Margin % | 14.1% | 16.2% | 17.5% | 18.6% | 18.8% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 1.4B | 1.3B | 1.1B | 1.0B | 883.5M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 1.4B | 1.3B | 1.1B | 1.0B | 883.5M |
Operating Income | 206.4M | 147.2M | 228.7M | 234.2M | 165.2M |
Operating Margin % | 1.8% | 1.7% | 3.0% | 3.5% | 3.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 228.4M | 324.6M | 233.6M | 165.3M | 139.0M |
Other Non-Operating Income | -12.7M | - | -40.9M | - | - |
Pre-tax Income | -34.7M | -177.4M | -45.8M | 68.9M | 26.2M |
Income Tax | -14.2M | -20.6M | 8.5M | 17.6M | 5.1M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 25.6% | 19.4% |
Net Income | -20.5M | -156.8M | -54.2M | 51.3M | 21.2M |
Net Margin % | -0.2% | -1.8% | -0.7% | 0.8% | 0.4% |
Key Metrics | |||||
EBITDA | 410.9M | 349.5M | 432.7M | 433.3M | 346.7M |
EPS (Basic) | $-0.09 | $-0.90 | $-0.31 | $0.29 | $0.12 |
EPS (Diluted) | $-0.09 | $-0.90 | $-0.31 | $0.29 | $0.12 |
Basic Shares Outstanding | 192997000 | 171190389 | 171190389 | 171190389 | 171190389 |
Diluted Shares Outstanding | 192997000 | 171190389 | 171190389 | 171190389 | 171190389 |
Income Statement Trend
BrightSpring Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 61.3M | 13.1M | 13.6M | 46.7M | 262.0M |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 1.0B | 881.6M | 775.8M | 730.3M | 625.6M |
Inventory | 640.6M | 402.8M | 430.5M | 299.2M | 300.1M |
Other Current Assets | 14.0M | 13.2M | 13.5M | 12.7M | 16.4M |
Total Current Assets | 1.9B | 1.5B | 1.3B | 1.2B | 1.3B |
Non-Current Assets | |||||
Property, Plant & Equipment | 347.3M | 350.8M | 317.2M | 356.0M | 292.8M |
Goodwill | 6.2B | 6.1B | 6.1B | 6.4B | 4.4B |
Intangible Assets | 811.5M | 881.5M | 975.9M | 1.1B | 1.1B |
Long-term Investments | 0 | 24.9M | 36.8M | 0 | - |
Other Non-Current Assets | 32.0M | 32.2M | 24.3M | 27.2M | 22.7M |
Total Non-Current Assets | 4.0B | 4.1B | 4.1B | 4.3B | 3.3B |
Total Assets | 5.9B | 5.5B | 5.4B | 5.5B | 4.5B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 941.3M | 641.6M | 526.9M | 408.1M | 355.8M |
Short-term Debt | 130.5M | 114.5M | 107.9M | 125.2M | 91.0M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 1.4B | 1.2B | 932.5M | 892.2M | 742.8M |
Non-Current Liabilities | |||||
Long-term Debt | 2.8B | 3.6B | 3.6B | 3.6B | 2.9B |
Deferred Tax Liabilities | 0 | 23.7M | 79.4M | 98.2M | 121.6M |
Other Non-Current Liabilities | 11.4M | 18.0M | 7.7M | 7.3M | 7.3M |
Total Non-Current Liabilities | 2.8B | 3.7B | 3.7B | 3.8B | 3.1B |
Total Liabilities | 4.3B | 4.9B | 4.7B | 4.7B | 3.8B |
Equity | |||||
Common Stock | 1.7M | 1.2M | 1.2M | 1.2M | 745.2M |
Retained Earnings | -222.2M | -200.3M | -45.7M | 971.0K | -51.8M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.7B | 612.5M | 784.1M | 800.5M | 735.4M |
Key Metrics | |||||
Total Debt | 2.9B | 3.7B | 3.7B | 3.8B | 3.0B |
Working Capital | 464.7M | 208.2M | 411.7M | 288.5M | 547.6M |
Balance Sheet Composition
BrightSpring Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -20.5M | -156.8M | -54.2M | 51.3M | 21.2M |
Depreciation & Amortization | 204.5M | 202.3M | 204.0M | 199.2M | 181.5M |
Stock-Based Compensation | 69.2M | 3.9M | 3.5M | 4.5M | 6.3M |
Working Capital Changes | -133.1M | 702.0K | -154.2M | -63.0M | -10.6M |
Operating Cash Flow | 103.7M | 17.8M | -5.7M | 219.7M | 230.2M |
Investing Activities | |||||
Capital Expenditures | -80.9M | -73.5M | -70.1M | -59.3M | -51.9M |
Acquisitions | -59.8M | -63.1M | 113.3M | -1.1B | -402.0M |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -140.2M | -134.4M | 45.4M | -1.2B | -452.9M |
Financing Activities | |||||
Share Repurchases | -650.0K | -650.0K | 0 | -417.0K | -1.1M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 2.6B | 0 | 0 | 767.7M | 550.0M |
Debt Repayment | -3.4B | -66.1M | -68.9M | -40.8M | -56.8M |
Financing Cash Flow | 163.1M | -67.5M | -74.0M | 705.0M | 473.6M |
Free Cash Flow | -57.1M | 137.3M | -74.8M | 210.9M | 170.7M |
Net Change in Cash | 126.6M | -184.1M | -34.4M | -266.0M | 250.9M |
Cash Flow Trend
BrightSpring Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
89.76
Forward P/E
27.04
Price to Book
2.62
Price to Sales
0.32
PEG Ratio
2.24
Profitability Ratios
Profit Margin
0.52%
Operating Margin
1.54%
Return on Equity
2.67%
Return on Assets
4.46%
Financial Health
Current Ratio
1.76
Debt to Equity
155.46
Per Share Data
EPS (TTM)
$0.25
Book Value per Share
$8.58
Revenue per Share
$62.84
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
btsg | 4.0B | 89.76 | 2.62 | 2.67% | 0.52% | 155.46 |
Veeva Systems | 45.6B | 59.15 | 7.33 | 14.06% | 27.34% | 1.24 |
Ge Healthcare | 33.5B | 15.04 | 3.45 | 25.80% | 11.22% | 107.67 |
HealthEquity | 7.8B | 65.61 | 3.67 | 5.77% | 9.80% | 52.11 |
Waystar Holding | 6.2B | 64.55 | 1.95 | 2.81% | 8.50% | 39.60 |
Privia Health | 2.6B | 192.00 | 3.79 | 2.71% | 0.78% | 0.91 |
Financial data is updated regularly. All figures are in the company's reporting currency.